Different Effects of Delayed Clamping on Neonatal Bilirubin Levels Between Pregnant Women With Intrahepatic Cholestasis of Pregnancy and Normal Pregnant Women

Sponsor
Second Affiliated Hospital of Wenzhou Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05637151
Collaborator
(none)
200
4
21.1

Study Details

Study Description

Brief Summary

Objective:The aim of this study was to investigate the relationship between delayed cord clamping and neonatal bilirubin levels in pregnant women with intrahepatic cholestasis of pregnancy.

Method:This observational prospective cohort study included a total of 200 pregnant women at 37-40 gestational weeks. Among them, 100 pregnant women with intrahepatic cholestasis of pregnancy were divided into 50 cases of immediate cord clamping group (ICC in pregnant women with ICP)and 50 cases of delayed cord clamping group(DCC in pregnant women with ICP), and 100 normal pregnant women were also divided into 50 cases of immediate cord clamping group (ICC in normal pregnant women)and 50 cases of delayed cord clamping group(DCC in normal pregnant women). The bilirubin levels of neonates in each group were compared.

Condition or Disease Intervention/Treatment Phase
  • Other: clamp time of umbilical
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Different Effects of Delayed Cord Clamping on Neonatal Bilirubin Levels Between Pregnant Women With Intrahepatic Cholestasis of Pregnancy and Normal Pregnant Women
Anticipated Study Start Date :
Mar 20, 2023
Anticipated Primary Completion Date :
Jun 20, 2024
Anticipated Study Completion Date :
Dec 20, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: ICC in pregnant women with ICP

Immediate cord clamping group in pregnant women with intrahepatic cholestasis of pregnancy

Other: clamp time of umbilical
The umbilical cord was clamped immediately or late for more than 30s

Experimental: DCC in pregnant women with ICP

Delayed cord clamping group in pregnant women with intrahepatic cholestasis of pregnancy

Other: clamp time of umbilical
The umbilical cord was clamped immediately or late for more than 30s

Other: ICC in normal pregnant women

Immediate cord clamping group in normal pregnant women

Other: clamp time of umbilical
The umbilical cord was clamped immediately or late for more than 30s

Experimental: DCC in normal pregnant women

Delayed cord clamping group in normal pregnant women

Other: clamp time of umbilical
The umbilical cord was clamped immediately or late for more than 30s

Outcome Measures

Primary Outcome Measures

  1. the neonatal bilirubin values [2-4 days after birth]

    the neonatal bilirubin values

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. The pregnant woman is born at a gestational age of 37-40 weeks;

  2. The pregnant woman has a single child;

  3. Regular obstetric examination durinv pregnancy with complete obstetric examination data was diagnosed as intrahepatic cholestasis of pregnancy(ICP).

Exclusion Criteria:
  1. Pregnancy complicated with medical and surgical diseases, such as thyroiddysfunction and chronic hypertension;

  2. Insufficiency of vital organ function or complicated tumor;

  3. Pregnant women with other pregnancy complications besides ICP, such as preeclampsia, etc.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Second Affiliated Hospital of Wenzhou Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital of Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT05637151
Other Study ID Numbers:
  • SAHoWMU-CR2022-07-206
First Posted:
Dec 5, 2022
Last Update Posted:
Jan 31, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Second Affiliated Hospital of Wenzhou Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 31, 2023